Axa’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-233,680
| Closed | -$7.43M | – | 1173 |
|
|
2023
Q2 | $7.43M | Buy |
233,680
+31,947
| +16% | +$1.02M | 0.02% | 471 |
|
|
2023
Q1 | $4.92M | Sell |
201,733
-468
| -0.2% | -$11.4K | 0.02% | 568 |
|
|
2022
Q4 | $6.38M | Buy |
202,201
+54,668
| +37% | +$1.72M | 0.02% | 529 |
|
|
2022
Q3 | $4.17M | Buy |
147,533
+22,377
| +18% | +$632K | 0.02% | 613 |
|
|
2022
Q2 | $3.31M | Sell |
125,156
-2,434
| -2% | -$64.4K | 0.01% | 675 |
|
|
2022
Q1 | $4.47M | Buy |
+127,590
| New | +$4.47M | 0.01% | 671 |
|